Precipitating factors of decompensation of heart failure related to treatment adherence: multicenter study-EMBRACE

Eneida Rejane Rabelo-Silva1,2, Marco Aurélio Lumertz Saffi2, Graziella Badin Aliti1,2

  • 1Universidade Federal do Rio Grande do Sul (UFRGS). Escola de Enfermagem. Porto Alegre, Rio Grande do Sul, Brasil.

Insights

Poor adherence to heart failure treatment is the primary cause of decompensation. Patients with irregular medication use face a significantly higher risk of hospitalization due to non-adherence.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Heart failure decompensation leads to frequent hospitalizations.
  • Patient adherence to treatment is crucial for managing heart failure.
  • Understanding precipitating factors of decompensation is vital for improving patient outcomes.

Purpose of the Study:

  • To identify and compare the factors leading to heart failure decompensation in patients with varying levels of treatment adherence.
  • To investigate the specific impact of non-adherence on the risk of heart failure exacerbation.

Main Methods:

  • A multicenter, cross-sectional cohort study was conducted.
  • 556 adult patients with decompensated heart failure (functional class III/IV) were enrolled.
  • Data on precipitating factors, including medication use and lifestyle, were collected via structured questionnaires.

Main Results:

  • Poor adherence was identified as the primary factor for decompensation, accounting for 55% of cases.
  • Patients reporting irregular medication use in the preceding week had a 22% increased risk of hospitalization due to non-adherence.
  • Inadequate salt and fluid intake were also noted as contributing factors to poor adherence.

Conclusions:

  • Poor adherence to treatment is the leading cause of heart failure exacerbation.
  • Interventions aimed at improving medication adherence are critical for reducing heart failure hospitalizations.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319